KDIGO AKI Staging
Stages acute kidney injury by creatinine rise from baseline or urine output criteria.
Score interpretation
No AKI criteria met.
→ Monitor renal function if clinical suspicion. Ensure adequate hydration.
KDIGO Stage 1: Mild AKI. Creatinine 1.5–1.9× baseline or rise ≥26.5 µmol/L in 48h.
→ Identify and treat cause. Stop nephrotoxins. Strict fluid balance. Monitor twice daily.
KDIGO Stage 2: Moderate AKI. Creatinine 2–2.9× baseline.
→ Nephrology input. Hourly urine output monitoring. Cautious fluid management. Avoid IV contrast.
KDIGO Stage 3: Severe AKI. Creatinine ≥3× baseline or ≥353.6 µmol/L or RRT.
→ Urgent nephrology. Consider RRT (CVVH/HD). HDU/ICU. Review all drug doses. Strict fluid balance.
Interpretation bands for the KDIGO AKI. Apply clinical judgement and local guidance.
References
- KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012.
Related
Curated clinical cross-links plus same-class fallbacks.
- Glyceryl Trinitrate (Sublingual / IV) · Nitrate / Acute Angina
- Dobutamine (Acute HF / Stress Echo) · Inotrope / Acute Heart Failure
- Milrinone · Inodilator / Acute Heart Failure
- Prednisolone (Systemic) · Systemic Corticosteroid — Acute Dermatoses
- Methoxyflurane · Inhaled Analgesic — Acute Pain
- Colchicine (Acute Gout) · Anti-Inflammatory (Microtubule Inhibitor)
- Difficult Airway Algorithm (DAS) · DAS 2015; Royal College of Anaesthetists
- Major Haemorrhage Protocol · NICE NG24; UK MHP guidelines
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.